Jieyao Li Selected Research

Lymphatic Metastasis

3/2017

Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jieyao Li Research Topics

Disease

9	Neoplasms (Cancer) 04/2023 - 01/2015
4	Lung Neoplasms (Lung Cancer) 04/2023 - 11/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2018
2	Esophageal Squamous Cell Carcinoma 10/2018 - 01/2015
2	Hypoxia (Hypoxemia) 01/2018 - 01/2017
2	Melanoma (Melanoma, Malignant) 03/2017 - 01/2015
1	Body Weight (Weight, Body) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Sepsis (Septicemia) 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Ventilator-Associated Pneumonia 01/2023
1	Adenocarcinoma 10/2020
1	Diabetes Mellitus 03/2020
1	Herpes Zoster 03/2020
1	Hepatitis C 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Adenocarcinoma of Lung 01/2018
1	Carcinogenesis 10/2017
1	Lymphatic Metastasis 03/2017
1	Esophageal Neoplasms (Esophageal Cancer) 08/2015
1	Neoplasm Metastasis (Metastasis) 08/2015

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 03/2020 - 10/2017
2	CytokinesIBA 04/2023 - 01/2015
2	Immune Checkpoint InhibitorsIBA 04/2023 - 01/2023
2	Docetaxel (Taxotere)FDA Link 06/2022 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 03/2017 - 01/2015
1	Amino Acids FDA Link 04/2023
1	Taurine FDA Link 04/2023
1	AntibodiesIBA 04/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	hemicelluloseIBA 01/2023
1	Bronchodilator Agents (Bronchodilators)IBA 01/2023
1	ElectrolytesIBA 01/2023
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023
1	Long Noncoding RNAIBA 01/2023
1	olaparibIBA 10/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020
1	Tight Junction ProteinsIBA 03/2020
1	NF-kappa B (NF-kB)IBA 10/2018
1	Interleukin-8 (Interleukin 8)IBA 10/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	MucinsIBA 01/2018
1	AMP-Activated Protein KinasesIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	CTLA-4 AntigenIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 10/2017
1	Insulin-Like PeptidesIBA 10/2017
1	Messenger RNA (mRNA)IBA 03/2017
1	AntigensIBA 03/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2017
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2015
1	Adapalene (Differin)FDA LinkGeneric 01/2015

Therapy/Procedure

6	Therapeutics 04/2023 - 01/2015
4	Drug Therapy (Chemotherapy) 01/2018 - 01/2015
1	Glycemic Control 01/2023
1	Critical Care (Surgical Intensive Care) 01/2023
1	Length of Stay 01/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2023
1	Immunotherapy 03/2017
1	Radiotherapy 08/2015